Publications by authors named "Giulia Ribelli"

Claim this Profile
O
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation.
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Silvia Cavaliere, Bruno Vincenzi

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.
Francesco Pantano, Francesca Zalfa, Michele Iuliani, Sonia Simonetti, Paolo Manca, Giulia Ribelli

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment.
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Andrea Napolitano, Umile Giuseppe Longo

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms.
Giulia Ribelli, Sonia Simonetti, Michele Iuliani, Elisabetta Rossi, Bruno Vincenzi

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma.
Michele Iuliani, Sonia Simonetti, Francesco Pantano, Giulia Ribelli, Alberto Di Martino

Biology (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz-Knoll, Michele Iuliani, Giulia Ribelli

Oncogene· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab for cancer-related bone loss.
Emanuela Dell'Aquila, Grazia Armento, Michele Iuliani, Sonia Simonetti, Loretta D'Onofrio, Giulia Ribelli

Expert Opin Biol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti

J Exp Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Biomarkers Predicting Bone Metastasis Development.
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Andrea Napolitano, Francesco Pantano

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti

J Exp Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer.
Francesco Pantano, Elisabetta Rossi, Michele Iuliani, Antonella Facchinetti, Sonia Simonetti, Giulia Ribelli

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis.
Francesca R Bertani, Pamela Mozetic, Marco Fioramonti, Michele Iuliani, Giulia Ribelli

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of bone specific metastasis in prostate cancer.
Paolo Manca, Francesco Pantano, Michele Iuliani, Giulia Ribelli, Delia De Lisi

Crit Rev Oncol Hematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
Marco Fioramonti, Daniele Santini, Michele Iuliani, Giulia Ribelli, Paolo Manca

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs for the treatment of bone metastasis.
Francesco Pantano, Michele Iuliani, Alice Zoccoli, Marco Fioramonti, Delia De Lisi, Giulia Ribelli

Expert Opin Emerg Drugs· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence.
Daniele Santini, Luciano Stumbo, Chiara Spoto, Loretta D'Onofrio, Francesco Pantano, Giulia Ribelli

Breast Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.
Michele Iuliani, Francesco Pantano, Consuelo Buttigliero, Marco Fioramonti, Valentina Bertaglia, Giulia Ribelli

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis